NNIT to ride Danish wave to IPO after Matas success

Pharmaceuticals firm Novo Nordisk said on Wednesday that it would list NNIT, an information technology subsidiary, seeking to take advantage of growing appetite for Danish stocks. The country is also seeing smaller firms looking to come to market for the first time in many years.

  • By Andrew Griffin
  • 17 Jan 2014

`NNIT is likely to be valued at around Dkr4bn-Dkr5bn ($732m-$915m) through the deal, with Novo Nordisk listing around a third of the company. The company generates Ebitda of around Dkr350m, with around 50% of its revenues coming from Novo Nordisk.

Local market participants identified NNTI as one company ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Barclays 20,041.00 34 7.66%
2 Citi 18,215.95 71 6.97%
3 JPMorgan 16,098.67 49 6.16%
4 Goldman Sachs 15,821.46 36 6.05%
5 HSBC 15,568.27 47 5.95%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 48,528.41 214 6.32%
2 Deutsche Bank 44,075.51 161 5.74%
3 BNP Paribas 41,452.79 240 5.40%
4 JPMorgan 37,278.65 134 4.85%
5 SG Corporate & Investment Banking 36,258.27 187 4.72%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Goldman Sachs 1,607.28 5 28.64%
2 Credit Suisse 1,301.65 4 23.20%
3 BNP Paribas 522.35 4 9.31%
4 SG Corporate & Investment Banking 444.17 3 7.92%
5 Morgan Stanley 331.78 2 5.91%